MENS
Jyong Biotech Ltd. Ordinary Shares NASDAQ Listed Jun 17, 2025$2.03
Mkt Cap $154.3M
52w Low $1.43
1.0% of range
52w High $63.00
50d MA $2.18
200d MA $2.72
P/E (TTM)
-20.6x
EV/EBITDA
—
P/B
—
Debt/Equity
-0.5x
ROE
—
P/FCF
-42.6x
RSI (14)
44.60
ATR (14)
$0.19
Beta
8.47
50d MA
$2.18
200d MA
$2.72
Avg Volume
44.0K
Jyong Biotech Ltd. is a Taiwan-based biotech firm focused on developing and commercializing plant-derived drugs targeting urinary system diseases. The company operates through its subsidiaries—Health Ever Bio-Tech, Genvace, and others—working on drug candidates like MCS‑2 (for BPH) currently in Phase III, PCP (for prostate cancer) in Phase II, and IC in pre-clinical stages
23F‑3, No. 95, Section 1, Xintai 5th Road · New Taipei City 221 · TW
Data updated apr 26, 2026 11:51am
· Source: financialmodelingprep.com